Wave Life Sciences Ltd. ($WVE)
Filing Information
| Accession Number | 0001193125-26-083712 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 28, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
99,582
Total Value
$641,512.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 17,900 | $3.87 | $69,273.00 | 79,767 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Feb 26, 2026 | Sale | 17,900 | $15.09 | $270,182.60 | 61,867 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Feb 26, 2026 | Exercise/Conversion | 15,294 | $4.75 | $72,646.50 | 77,161 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Ordinary Shares | โ | Feb 26, 2026 | Sale | 15,294 | $15.00 | $229,410.00 | 61,867 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Share Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 17,900 | $0.00 | $0.00 | 143,200 | Direct | โ | View Details | |
SVP, Corporate Development, Head of Emerging Areas | Share Option (right to buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 15,294 | $0.00 | $0.00 | 61,175 | Direct | โ | View Details |